Vasodilator effect of human urotensin-II on human pulmonary and resistance arteries

被引：0
|
作者：
Stirrat, A
Douglas, A
Kirk, A
Berry, C
Richardson, M
MacLean, MR
机构：
[1] Univ Glasgow, IBLS, Div Neurosci & Biomed Syst, Glasgow G12 8QQ, Lanark, Scotland
[2] Glasgow Western Infirm, Dept Cardiovasc Surg, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Western Infirm, Dept Surg, Glasgow G11 6NT, Lanark, Scotland
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2000年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
88P
引用
收藏
页码：U50 / U50
页数：1
相关论文
共 50 条
  • [31] Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure
    Dschietzig, T
    Bartsch, C
    Pregla, R
    Zurbrügg, HR
    Armbruster, FP
    Richter, C
    Laule, M
    Romeyke, E
    Neubert, C
    Voelter, W
    Baumann, G
    Stangl, K
    REGULATORY PEPTIDES, 2002, 110 (01) : 33 - 38
  • [32] Modeling and docking studies of human urotensin-II receptor in inactive and active state
    di Bosco, A. Mazzella
    Saviano, M.
    Carotenuto, A.
    Auriemma, L.
    Campiglia, P.
    Novellino, E.
    Grieco, P.
    BIOPOLYMERS, 2007, 88 (04) : 603 - 603
  • [33] Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure
    Russell, FD
    Meyers, D
    Galbraith, AJ
    Bett, N
    Toth, I
    Kearns, P
    Molenaar, P
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (04): : H1576 - H1581
  • [34] Development of potent and selective small-molecule human Urotensin-II antagonists
    McAtee, John J.
    Dodson, Jason W.
    Dowdell, Sarah E.
    Girard, Gerald R.
    Goodman, Krista B.
    Hilfiker, Mark A.
    Sehon, Clark A.
    Sha, Deyou
    Wang, Gren Z.
    Wang, Ning
    Viet, Andrew Q.
    Zhang, Daohua
    Aiyar, Nambi V.
    Behm, David J.
    Carballo, Luz H.
    Evans, Christopher A.
    Fries, Harvey E.
    Nagilla, Rakesh
    Roethke, Theresa J.
    Xu, Xiaoping
    Yuan, Catherine C. K.
    Douglas, Stephen A.
    Neeb, Michael J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3500 - 3503
  • [35] Renal effects of human urotensin-II in rats with experimental congestive heart failure
    Ovcharenko, E
    Abassi, Z
    Rubinstein, I
    Kaballa, A
    Hoffman, A
    Winaver, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (05) : 1205 - 1211
  • [36] Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy human subjects
    Sidharta, PN
    van Giersbergen, PLM
    Schaarschmidt, D
    Dingemanse, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1192 - 1192
  • [37] Production and characterization of monoclonal antibodies against the vasoconstrictive peptide human urotensin-II
    Su, JL
    Ao, ZH
    Aiyar, NV
    Ellis, B
    Martin, JD
    Douglas, SA
    Kull, FC
    HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (06): : 377 - 382
  • [38] Effects of urotensin II in human arteries and veins of varying caliber
    Hillier, C
    Berry, C
    Petrie, MC
    O'Dwyer, PJ
    Hamilton, C
    Brown, A
    McMurray, J
    CIRCULATION, 2001, 103 (10) : 1378 - 1381
  • [39] Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats
    Gendron, G
    Simard, B
    Gobeil, F
    Sirois, P
    D'Orléans-Juste, P
    Regoli, D
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2004, 82 (01) : 16 - 21
  • [40] Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries
    Katano, Y
    Ishihata, A
    Aita, T
    Ogaki, T
    Horie, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 402 (1-2) : R5 - R7
12345